Auckland Cancer Research Network seminar: Translation of the g-H2AX assay to radiation oncology Event as iCalendar

28 March 2013

2 - 3pm

Venue: Seminar Room 505-003, Building 505, 85 Park Road, Grafton

Olga Martin obtained her PhD in Cancer Biology in 1993 at the Cancer Research Centre of Russian Federation, Moscow, Russia. In 1994-1999 she had her professional training as a Postdoctoral Fellow at the Department of Nuclear Medicine, Clinical Centre, NIH, Bethesda, USA, where she got involved in molecular cancer and radiation biology research.

During more than 10 years in Bill Bonner’s lab at NIH, where the g-H2AX assay was discovered, Olga developed a comprehensive interest and expertise in the general field of DNA damage and repair. From this base, she has exploited the particular advantages of the assay (namely exquisite sensitivity and rapidity of DNA damage response) in a wide variety of biological contexts. Thus, Olga’s research and publications have embraced aging, carcinogenesis, cell-cell communication, radiation biology and biodosimetry.

More recently, her interests have focused on clinical challenges, particularly in radiation oncology. She will talk on the application of the ?H2AX assay for measurement of individual radiosensitivity and for detection and separation of circulating tumour cells in lung cancer patients undergoing radiotherapy treatment.